Screener
Monte Rosa Therapeutics, Inc. GLUE Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.04B.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
FAQ
- What is Monte Rosa Therapeutics, Inc.'s market capitalization?
- Monte Rosa Therapeutics, Inc. (GLUE) reported market capitalization of $2.04B in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s market capitalization changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s market capitalization increased by 601.2% year-over-year, from $291.56M to $2.04B.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s market capitalization?
- Over 4 years (2021 to 2025), Monte Rosa Therapeutics, Inc.'s market capitalization has grown at a 1.8% compound annual growth rate (CAGR), from $951.49M to $1.02B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Monte Rosa Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude